epoch-r
Epoch R is a drug used to treat Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive, Lymphoma, Mantle Cell, and other conditions. Epoch R is being actively studied in 1 study and prior, has been studied in 1.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
National Cancer Institute (NCI) | National Institutes of Health Clinical Center, 9000 Rockville Pike | Mark Roschewski, M.D. |
Beth Israel Deaconess Medical Center | ||
Case Western Reserve University |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Completed
- Mantle Cell Lymphoma
- Lymphoma, Mantle Cell
- EPOCH-R
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-24
Mar 24, 2022N
Active, not recruiting
- Burkitt Lymphoma
- +2 more
- EPOCH-R
- EPOCH-RR
- La Jolla, California
- +29 more
2021-11-02
Nov 2, 2021